SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-153190
Filing Date
2020-05-27
Accepted
2020-05-27 17:00:13
Documents
12
Period of Report
2020-05-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d863100d8k.htm   iXBRL 8-K 60506
  Complete submission text file 0001193125-20-153190.txt   185500

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gwph-20200526.xsd EX-101.SCH 3067
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20200526_lab.xml EX-101.LAB 18071
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20200526_pre.xml EX-101.PRE 11382
13 EXTRACTED XBRL INSTANCE DOCUMENT d863100d8k_htm.xml XML 3568
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35892 | Film No.: 20916061
SIC: 2834 Pharmaceutical Preparations